Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Author index

Page Path
HOME > Browse articles > Author index
Search
Jin-Kyoung Park 1 Article
Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway
Kieu Thi Thu Trang, Se-Lim Kim, Sang-Bae Park, Seung-Young Seo, Chung-Hwan Choi, Jin-Kyoung Park, Jin-Chang Moon, Soo-Teik Lee, Sang-Wook Kim
Intest Res 2014;12(1):34-41.   Published online January 28, 2014
DOI: https://doi.org/10.5217/ir.2014.12.1.34
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Combination therapy utilizing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in conjunction with other anticancer agents, is a promising strategy to overcome TRAIL resistance in malignant cells. Recently, parthenolide (PT) has proved to be a promising anticancer agent, and several studies have explored its use in combination therapy. Here, we investigated the molecular mechanisms by which PT sensitizes colorectal cancer (CRC) cells to TRAIL-induced apoptosis.

Methods

HT-29 cells (TRAIL-resistant) were treated with PT and/or TRAIL for 24 hours. The inhibitory effect on proliferation was detected using the 3-(4, 5-dimethylthiazol-2yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Annexin V staining, cell cycle analysis, and Hoechst 33258 staining were used to assess apoptotic cell death. Activation of an apoptotic pathway was confirmed by Western blot.

Results

Treatment with TRAIL alone inhibited the proliferation of HCT 116 cells in a dose-dependent manner, whereas proliferation was not affected in HT-29 cells. Combination PT and TRAIL treatment significantly inhibited cell growth and induced apoptosis of HT-29 cells. We observed that the synergistic effect was associated with misregulation of B-cell lymphoma 2 (Bcl-2) family members, release of cytochrome C to the cytosol, activation of caspases, and increased levels of p53.

Conclusion

Combination therapy using PT and TRAIL might offer an effetive strategy to overcome TRAIL resistance in certain CRC cells.

Citations

Citations to this article as recorded by  
  • Nanomagnetic Liposome-Encapsulated Parthenolide and Indocyanine Green for Targeting and Chemo-Photothermal Antitumor Therapy
    Wenbin Gao, Lei Li, Xuwu Zhang, Liyao Luo, Yuchu He, Cong Cong, Dawei Gao
    Nanomedicine.2020; 15(9): 871.     CrossRef
  • Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy
    Wenbin Gao, Shipan Wei, Zhuo Li, Lei Li, Xuwu Zhang, Chunhui Li, Dawei Gao
    Nanotechnology.2020; 31(35): 355104.     CrossRef
  • Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells
    Arash Ghorbani-Abdi-Saedabad, Mohammad Yahya Hanafi-Bojd, Negin Parsamanesh, Zahra Tayarani-Najaran, Homa Mollaei, Reyhane Hoshyar
    Molecular Biology Reports.2020; 47(8): 5807.     CrossRef
  • Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
    Malgorzata Sztiller-Sikorska, Malgorzata Czyz
    Pharmaceuticals.2020; 13(8): 194.     CrossRef
  • Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
    Ali Hassanzadeh, Majid Farshdousti Hagh, Mohammad Reza Alivand, Ali Akbar Movassaghpour Akbari, Karim Shams Asenjan, Raedeh Saraei, Saeed Solali
    Journal of Cellular Physiology.2018; 233(10): 6470.     CrossRef
  • Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species
    Gabriela Flores‐Lopez, Dafne Moreno‐Lorenzana, Manuel Ayala‐Sanchez, Socrates Aviles‐Vazquez, Hector Torres‐Martinez, Peter A. Crooks, Monica L. Guzman, Hector Mayani, Antonieta Chávez‐González
    Journal of Cellular and Molecular Medicine.2018; 22(10): 4899.     CrossRef
  • Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation
    Se-Lim Kim, Seong Hun Kim, Young Ran Park, Yu-Chuan Liu, Eun-Mi Kim, Hwan-Jeong Jeong, Yo Na Kim, Seung Young Seo, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang-Wook Kim
    Molecular Cancer Research.2017; 15(2): 141.     CrossRef
  • Protective effects of Alpha-lipoic acid on MeHg-induced oxidative damage and intracellular Ca2+dyshomeostasis in primary cultured neurons
    Tianyao Yang, Zhaofa Xu, Wei Liu, Bin Xu, Yu Deng
    Free Radical Research.2016; 50(5): 542.     CrossRef
  • Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats
    Gracianny Gomes Martins, Francislaine Aparecida dos Reis Lívero, Aline Maria Stolf, Caroline Machado Kopruszinski, Cibele Campos Cardoso, Olair Carlos Beltrame, José Ederaldo Queiroz-Telles, Regiane Lauriano Batista Strapasson, Maria Élida Alves Stefanell
    Chemico-Biological Interactions.2015; 228: 46.     CrossRef
  • Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
    Hyun-Young Kim, Se-Lim Kim, Young-Ran Park, Yu-Chuan Liu, Seung Young Seo, Seong Hun Kim, In Hee Kim, Seung Ok Lee, Soo Teik Lee, Sang Wook Kim
    Intestinal Research.2015; 13(3): 233.     CrossRef
  • Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation
    THANET SOPHONNITHIPRASERT, SIRINUN NILWARANGKOON, YUKIO NAKAMURA, RAMIDA WATANAPOKASIN
    International Journal of Oncology.2015; 47(6): 2188.     CrossRef
  • 8,712 View
  • 47 Download
  • 15 Web of Science
  • 11 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP